跳至主要内容
临床试验/ACTRN12611000505909
ACTRN12611000505909已完成未知

The effectiveness of hyperbaric oxygen therapy (HBOT) for healing chronic venous leg ulcers: A randomised, double blind, placebo-controlled trial

Collaborate Sponsorship: Wesley Centre for Hyperbaric Medicine, Queensland University of Technology, and the Wound Management Innovation CRC0 个研究点目标入组 84 人开始时间: 2011年5月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Persons presenting with a venous leg ulcer that have an Ankle branchial pressure index between 0.8 and 1.2, a TCOM reading that indicates a hypoxic wound responsive to an oxygen challenge, who are not at risk for hyperbaric-related complications and whose ulcer has not responded to standard treatment (i.e., <50% reduction in ulcer area following 4 weeks of treatment.

排除标准

  • 1. Persons with cognitive impairment.
  • 2. Persons with an Ankle Branchial Pressure Index <0.8 or >1.2.
  • 3. Persons with leg ulcers of non-venous aetiology.
  • 4. Persons considered to be at specific risk for hyperbaric-related complications, as specified below:
  • -pregnancy
  • -concurrent administration of disulfuram, or antineoplastic agents doxorubicin and cisplatinum.
  • -reactive airway disease (COPD with CO2 retention), radiographic evidence of pulmonary blebs/bullae
  • -untreated pneumothorax or history of spontaneous pneumothorax
  • -previous documented ejection fraction less than 35% or cardiovascular instability
  • -history of seizures - except childhood febrile seizures
  • -unable to follow simple commands, not orientated to person, place, time.
  • -prior chest surgery, middle ear surgery, optic neuritis, fever, congenital , spherocytosis, claustrophobia.

研究者

发起方
Collaborate Sponsorship: Wesley Centre for Hyperbaric Medicine, Queensland University of Technology, and the Wound Management Innovation CRC

相似试验